SerpinB13 antibodies promote β cell development and resistance to type 1 diabetes
- 7 April 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (588)
- https://doi.org/10.1126/scitranslmed.abf1587
Abstract
Pancreatic endocrine cell development is dependent on the rescue of the neurogenin3 (Ngn3) transcription factor from repression by Notch. The signals that prevent Notch signaling, thereby allowing the formation of pancreatic endocrine cells, remain unclear. We show that inhibiting serpinB13, a cathepsin L (CatL) protease inhibitor expressed in the pancreatic epithelium, caused in vitro and in vivo cleavage of the extracellular domain of Notch1. This was followed by a twofold increase in the Ngn3+ progenitor cell population and enhanced conversion of these cells to express insulin. Conversely, both recombinant serpinB13 protein and CatL deficiency down-regulated pancreatic Ngn3+ cell output. Mouse embryonic exposure to inhibitory anti-serpinB13 antibody resulted in increased islet cell mass and improved outcomes in streptozotocin-induced diabetes at 8 weeks of age. Moreover, anti-serpinB13 autoantibodies stimulated Ngn3+ endocrine progenitor formation in the pancreas and were associated with delayed progression to type 1 diabetes (T1D) in children. These data demonstrate long-term impact of serpinB13 activity on islet biology and suggest that promoting protease activity by blocking this serpin may have prophylactic potential in T1D.Keywords
Funding Information
- American Diabetes Association (1-17-ICTS-083)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK108739-01A1)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK108739-01A1)
- Juvenile Diabetes Research Foundation International (17-2013-428)
- ASCRS Research Foundation (17-2013-428)
- Diabetesforbundet (1-17-ICTS-083)
This publication has 41 references indexed in Scilit:
- Anti-serpin Antibody-mediated Regulation of Proteases in Autoimmune DiabetesOnline Journal of Public Health Informatics, 2013
- In vivo reprogramming of Sox9 + cells in the liver to insulin-secreting ductsProceedings of the National Academy of Sciences of the United States of America, 2012
- A System for ex vivo Culturing of Embryonic PancreasJournal of Visualized Experiments, 2012
- Enhanced Anti-Serpin Antibody Activity Inhibits Autoimmune Inflammation in Type 1 DiabetesThe Journal of Immunology, 2012
- Notch-mediated patterning and cell fate allocation of pancreatic progenitor cellsDevelopment, 2012
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- An Intracellular Serpin Regulates Necrosis by Inhibiting the Induction and Sequelae of Lysosomal InjuryCell, 2007
- The Squamous Cell Carcinoma Antigen 2 Inhibits the Cysteine Proteinase Activity of a Major Mite Allergen, Der p 1Online Journal of Public Health Informatics, 2004
- Inhibition of gastrulation in Xenopus embryos by an antibody against a cathepsin L‐like proteaseDevelopment, Growth & Differentiation, 1997
- The ovalbumin family of serpin proteinsFEBS Letters, 1993